Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (14), 2082-2084
- https://doi.org/10.1016/0959-8049(94)00356-a
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinomaEuropean Journal Of Cancer, 1992
- CA-125 is not a useful marker in metastatic breast cancerBritish Journal of Cancer, 1992
- Serum CA125 level is a good prognostic indicator in lung cancerBritish Journal of Cancer, 1990
- Elevated CA125 levels in patients with metastatic breast carcinomaBritish Journal of Cancer, 1990
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.Journal of Clinical Oncology, 1987
- Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive SystemThe American Journal of the Medical Sciences, 1986
- Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.Journal of Clinical Investigation, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958